BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
114 results:

  • 1. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
    Govind K; Paruk IM; Motala AA
    BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma.
    Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
    Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
    Gizaw M; Parkin DM; Stöter O; Bukirwa P; Seife E; Chesumbai G; Korir A; Liu B; Manraj SS; Nda G; Somdyala NIM; Kantelhardt EJ
    Int J Cancer; 2024 Jun; 154(11):1911-1919. PubMed ID: 38339849
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Closing the diagnostic gap: Liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa.
    Kokori E; Olatunji G; Ogieuhi IJ; Muogbo I; Isarinade D; Ukoaka B; Ajayi I; Ezenwoba C; Samuel O; Nurudeen-Busari H; Olawade DB; Aderinto N
    Medicine (Baltimore); 2024 Feb; 103(5):e37154. PubMed ID: 38306573
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian cancer.
    Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
    Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Georgakopoulos A
    Hell J Nucl Med; 2023; 26 Suppl():49-51. PubMed ID: 37658564
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Reticular fibre structure in the differential diagnosis of parathyroid neoplasms.
    Hu X; He S; Jiang X; Wei P; Zhou X; Shi Z; Li X; Lu J; Zhao H; Wei B; Jin M
    Diagn Pathol; 2023 Jul; 18(1):79. PubMed ID: 37403167
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
    Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
    Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Surgical management of prepubertal testicular tumors: A 30-year study in our institution.
    Nishio H; Mizuno K; Kato T; Kamisawa H; Kurokawa S; Nakane A; Maruyama T; Kawai N; Yasui T; Hayashi Y
    Int J Urol; 2023 Jun; 30(6):521-525. PubMed ID: 36861413
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
    Stiefel R; Lehmann K; Winder T; Siebenhüner AR
    BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Resistance of neuroendocrine tumours to somatostatin analogs.
    Angelousi A; Koumarianou A; Chatzellis E; Kaltsas G
    Expert Rev Endocrinol Metab; 2023 Jan; 18(1):33-52. PubMed ID: 36651768
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma.
    Zhang X; Wakabayashi H; Hiromasa T; Kayano D; Kinuya S
    Semin Nucl Med; 2023 Jul; 53(4):503-516. PubMed ID: 36641337
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Trends in the incidence of ovarian cancer in sub-Saharan Africa.
    Gizaw M; Parkin DM; Stöter O; Korir A; Kamate B; Liu B; Bojang L; N'Da G; Manraj SS; Bukirwa P; Chokunonga E; Chingonzoh T; Peko JF; Finesse A; Somdyala N; Ladipo A; Kantelhardt EJ
    Int J Cancer; 2023 Apr; 152(7):1328-1336. PubMed ID: 36274630
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study.
    Durmuş ET; Atmaca A; Kefeli M; Çalışkan S; Mete O; Aslan K; Fidan M; Çolak R; Durmuş B
    Growth Horm IGF Res; 2022 Dec; 67():101502. PubMed ID: 36115256
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Risk Stratification Model for Metastatic Lymph Nodes of Papillary Thyroid cancer: A Retrospective Study Based on Sonographic Features.
    Ni X; Xu S; Zhan W; Zhou W
    Front Endocrinol (Lausanne); 2022; 13():942569. PubMed ID: 35937798
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Saikosaponin-A Exhibits Antipancreatic cancer Activity by Targeting the EGFR/PI3K/Akt Pathway.
    Shi C; Sun L; Fang R; Zheng S; Yu M; Li Q
    Curr Pharm Biotechnol; 2023; 24(4):579-588. PubMed ID: 35692139
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Real-world comparison of healthcare resource utilization and costs of [
    Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
    Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Construction of a Diagnostic Model for Lymph Node Metastasis of the Papillary Thyroid Carcinoma Using Preoperative Ultrasound Features and Imaging Omics.
    Zhang C; Cheng L; Zhu W; Zhuang J; Zhao T; Li X; Wang W
    J Healthc Eng; 2022; 2022():1872412. PubMed ID: 35178222
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High Prevalence of Early endocrine Disorders After Childhood Brain Tumors in a Large Cohort.
    González Briceño LG; Kariyawasam D; Samara-Boustani D; Giani E; Beltrand J; Bolle S; Fresneau B; Puget S; Sainte-Rose C; Alapetite C; Pinto G; Piketty ML; Brabant S; Abbou S; Aerts I; Beccaria K; Bourgeois M; Roujeau T; Blauwblomme T; Di Rocco F; Thalassinos C; Pauwels C; Rigaud C; James S; Busiah K; Simon A; Bourdeaut F; Lemelle L; Guerrini-Rousseau L; Orbach D; Touraine P; Doz F; Dufour C; Grill J; Polak M
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2156-e2166. PubMed ID: 34918112
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.